Parkinson’s Drug Eyed as Treatment for Severe Macular Degeneration
WEDNESDAY, Sept. 16, 2020 (HealthDay News) — A drug long used to treat Parkinson’s disease may benefit patients with a severe form of age-related macular degeneration (AMD), a small clinical trial suggests. One of the leading causes of vision loss in older people is a condition called dry macular degeneration.Continue Reading